| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | BKT5F9C2NI |
| InChI Key | QJZRFPJCWMNVAV-HHHXNRCGSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C30H33ClN4O2 |
| Molecular Weight | 517.07 |
| AlogP | 5.59 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 81.22 |
| Molecular species | BASE |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 37.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | 24300 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 4100 | - | - | - | |
|
Enzyme
Hydrolase
|
- | - | - | - | 4 | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 4810 | - | - | - | |
|
Other cytosolic protein
|
- | 5-47 | - | 2-3 | 100 | |
|
Unclassified protein
|
- | - | - | - | 7 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colonic Neoplasms | 2 | D003110 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
| Liver Neoplasms | 2 | D008113 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 336113-53-2 |
| ChEBI | 94692 |
| ChEMBL | CHEMBL228814 |
| DrugBank | DB06188 |
| EPA CompTox | DTXSID20187307 |
| FDA SRS | BKT5F9C2NI |
| PDB | G7X |
| PubChem | 6851740 |
| SureChEMBL | SCHEMBL3582165 |
| ZINC | ZINC000011680799 |